Association Between Periprocedural Bleeding and Long-Term Outcomes Following Percutaneous Coronary Intervention in Older Patients

Autor: William S. Weintraub, Sumeet Subherwal, Sunil V. Rao, Ralph S. Brindis, Eric D. Peterson, Renato D. Lopes, David Dai, John C. Messenger
Rok vydání: 2012
Předmět:
Male
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Hemorrhage
Comorbidity
Kaplan-Meier Estimate
elderly patients
Patient Readmission
Risk Assessment
Antithrombins
Centers for Medicare and Medicaid Services
U.S

Article
Sex Factors
Risk Factors
medicine
Humans
Bivalirudin
Hospital Mortality
Registries
cardiovascular diseases
Aged
Proportional Hazards Models
Aged
80 and over

Chi-Square Distribution
business.industry
Proportional hazards model
percutaneous coronary intervention
Hazard ratio
Age Factors
Percutaneous coronary intervention
Hirudins
medicine.disease
Peptide Fragments
Recombinant Proteins
United States
periprocedural bleeding
Surgery
Treatment Outcome
Conventional PCI
Female
Cardiology and Cardiovascular Medicine
business
Chi-squared distribution
Mace
medicine.drug
Zdroj: JACC: Cardiovascular Interventions. 5:958-965
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2012.05.010
Popis: Objectives The authors sought to describe the association between post-procedural bleeding and long-term recurrent bleeding, major adverse cardiac events (MACE), and mortality among older patients undergoing percutaneous coronary intervention (PCI). Background Bleeding complications after PCI are associated with an increased risk for acute morbidity and long-term mortality, but the association of these bleeding complications with other events is unknown. Methods Patients entered into the National Cardiovascular Data Registry (NCDR) CathPCI Registry (n = 461,311; 946 sites) from January 2004 to December 2008 were linked with claims from the Centers for Medicare & Medicaid Services and grouped according to in-hospital post-PCI bleeding. The association between post-PCI bleeding and 1-, 12-, and 30-month readmission for bleeding, MACE, and all-cause mortality was examined with Cox regression that included patient and procedural characteristics using no bleeding as the reference. Results Overall, 3.1% (n = 14,107) of patients experienced post-PCI bleeding. Patients who bled were older, more often female, had more medical comorbidities, less often received bivalirudin, and more often underwent PCI via the femoral approach. After adjustment, bleeding after the index procedure was significantly associated with readmission for bleeding (adjusted hazard ratios [95% confidence interval]: 1 month, 1.54 [1.42 to 1.67]; 12 months, 1.52 [1.40 to 1.66]; 30 months, 1.29 [1.11 to 1.50]), MACE (1 month, 1.11 [1.07 to 1.15]; 12 months, 1.17 [1.13 to 1.21]; 30 months, 1.12 [1.06 to 1.19]) and all-cause mortality (1 month, 1.32 [1.26 to 1.38]; 12 months, 1.33 [1.27 to 1.40]); 30 months, 1.22 [1.15 to 1.30]). Conclusions Post-PCI bleeding complications are associated with an increased risk for short- and long-term recurrent bleeding, MACE, and all-cause mortality. These data underscore the prognostic importance of periprocedural bleeding and the need for identifying strategies to reduce long-term bleeding risk among patients undergoing PCI.
Databáze: OpenAIRE